AngioDynamics (ANGO) Misses Q2 EPS by 2c; Offers Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.44 +0.46%
Revenue Growth %: +6.3%
Financial Fact:
Income before income tax provision: 2.9M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +6.3%
Financial Fact:
Income before income tax provision: 2.9M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q2 EPS of ($0.02), $0.02 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $78.3 million versus the consensus estimate of $77.88 million.
GUIDANCE:
AngioDynamics sees FY2022 EPS of ($0.02)-$0.02, versus the consensus of $0.02. AngioDynamics sees FY2022 revenue of $310-315 million, versus the consensus of $313.7 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
